Myocardial viability and survival in ischemic left ventricular dysfunction

New England Journal of Medicine

Volumn 364, Issue 17, 2011, Pages 1617-1625

  Bonow, Robert O ^a   Maurer, Gerald ^b   Lee, Kerry L ^c   Holly, Thomas A ^a   Binkley, Philip F ^d   Desvigne Nickens, Patrice ^e   Drozdz, Jaroslaw ^f   Farsky, Pedro S ^h   Feldman, Arthur M ^j   Doenst, Torsten ^k   Michler, Robert E ^l   Berman, Daniel S ^m   Nicolau, Jose C ⁱ   Pellikka, Patricia A ⁿ   Wrobel, Krzysztof ^g   Alotti, Nasri ^o   Asch, Federico M ^p   Favaloro, Liliana E ^q   She, Lilin ^c   Velazquez, Eric J ^c   Jones, Robert H ^c   Panza, Julio A ^p   more..

^a NORTHWESTERN UNIVERSITY   (United States)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

^c DUKE UNIVERSITY MEDICAL CENTER   (United States)

^d THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

^e Department of Health and Human Services Imaging Laboratory National Heart Lung and Blood Institute   (United States)

^f MEDICAL UNIVERSITY OF LODZ   (Poland)

^g Krakowski Szpital Specjalistyczny Im Jana Pawła II   (Poland)

^h INSTITUTO DANTE PAZZANESE DE CARDIOLOGIA   (Brazil)

ⁱ UNIVERSITY OF SÃO PAULO   (Brazil)

^j THOMAS JEFFERSON UNIVERSITY   (United States)

^k UNIVERSITY OF LEIPZIG   (Germany)

^l ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^m CEDARS SINAI MEDICAL CENTER   (United States)

ⁿ MAYO CLINIC   (United States)

^o Zala County Hospital   (Hungary)

^p WASHINGTON HOSPITAL CENTER   (United States)

^q HOSPITAL UNIVERSITARIO FUNDACIÓN FAVALORO   (Argentina)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ADULT; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; ELECTROCARDIOGRAM; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FAILURE; HEART MUSCLE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

EID: 79955486739     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMoa1100358     Document Type: Article

References (45)

1. Gheorghiade M, Sopko G, De Luca L, et al. Navigating the crossroads of coronary artery disease and heart failure. Circulation 2006;114:1202-13. (Pubitemid 44386485)
2. Hunt SA, Abraham WT, Chin MH, et al. ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure). Circulation 2005;112(12):e154-e235.
3. Lloyd-Jones D, Adams RJ, Brown TM, et al. Heart disease and stroke statistics - 2010 update: a report from the American Heart Association. Circulation 2010; 121(7):e46-e215.
4. Felker GM, Shaw LK, O'Connor CM. A standardized definition of ischemic cardiomyopathy for use in clinical research. J Am Coll Cardiol 2002;39:210-8. (Pubitemid 34084623)
5. Velazquez EJ, Lee KL, O'Connor CM, et al. The rationale and design of the Surgical Treatment for Ischemic Heart Failure (STICH) Trial. J Thorac Cardiovasc Surg 2007;134:1540-7.
6. Velazquez EJ, Lee KL, Deja MA, et al. Coronary-artery bypass surgery in patients with left ventricular dysfunction. N Engl J Med 2011;364:1607-16.
7. Dilsizian V, Bonow RO. Current diagnostic techniques of assessing myocardial viability in hibernating and stunned myocardium. Circulation 1993;87:1-20. [Erratum, Circulation 1993;87:2070.] (Pubitemid 23019329)
8. Allman KC, Shaw LJ, Hachamovitch R, Udelson JE. Myocardial viability testing and impact of revascularization on prognosis in patients with coronary artery disease and left ventricular dysfunction: a meta-analysis. J Am Coll Cardiol 2002;39:1151-8. (Pubitemid 34267418)
9. Elefteriades JA, Tolis G Jr, Levi E, Mills LK, Zaret BL. Coronary artery bypass grafting in severe left ventricular dysfunction: excellent survival with improved ejection fraction and functional state. J Am Coll Cardiol 1993;22:1411-7. (Pubitemid 23316367)
10. Gioia G, Powers J, Heo J, Iskandrian AS. Prognostic value of rest-redistribution tomographic thallium-201 imaging in ischemic cardiomyopathy. Am J Cardiol 1995;75:759-62.
11. Gioia G, Milan E, Giubbini R, DePace N, Heo J, Iskandrian AS. Prognostic value of tomographic rest-redistribution thallium 201 imaging in medically treated patients with coronary artery disease and left ventricular dysfunction. J Nucl Cardiol 1996;3:150-6. (Pubitemid 26134971)
12. Williams MJ, Odabashian J, Lauer MS, Thomas JD, Marwick TH. Prognostic value of dobutamine echocardiography in patients with left ventricular dysfunction. J Am Coll Cardiol 1996;27:132-9. (Pubitemid 26018927)
13. Pagley PR, Beller GA, Watson DD, Gimple LW, Ragosta M. Improved outcome after coronary bypass surgery in patients with ischemic cardiomyopathy and residual myocardial viability. Circulation 1997;96:793-800. (Pubitemid 27329611)
14. Petretta M, Cuocolo A, Bonaduce D, et al. Incremental prognostic value of thallium reinjection after stress-redistribution imaging in patients with previous myocardial infarction and left ventricular dysfunction. J Nucl Med 1997;38:195-200. (Pubitemid 27061592)
15. Cuocolo A, Petretta M, Nicolai E, et al. Successful coronary revascularization improves prognosis in patients with previous myocardial infarction and evidence of viable myocardium at thallium-201 imaging. Eur J Nucl Med 1998;25:60-8. (Pubitemid 28107905)
16. Afridi I, Grayburn PA, Panza JA, Oh JK, Zoghbi WA, Marwick TH. Myocardial viability during dobutamine echocardiog-raphy predicts survival in patients with coronary artery disease and severe left ventricular systolic dysfunction. J Am Coll Cardiol 1998;32:921-6. (Pubitemid 28459579)
17. Anselmi M, Golia G, Cicoira M, et al. Prognostic value of detection of myocardial viability using low-dose dobutamine echocardiography in infarcted patients. Am J Cardiol 1998;81:21G-28G. (Pubitemid 28309276)
18. Pasquet A, Robert A, D'Hondt AM, Dion R, Melin JA, Vanoverschelde JL. Prognostic value of myocardial ischemia and viability in patients with chronic left ventricular ischemic dysfunction. Circulation 1999;100:141-8. [Erratum, Circulation 1999;100:1584.] (Pubitemid 29330012)
19. Senior R, Kaul S, Lahiri A. Myocardial viability on echocardiography predicts long-term survival after revascularization in patients with ischemic congestive heart failure. J Am Coll Cardiol 1999;33: 1848-54.
20. Chaudhry FA, Tauke JT, Alessandrini RS, Vardi G, Parker MA, Bonow RO. Prognostic implications of myocardial contractile reserve in patients with coronary artery disease and left ventricular dysfunction. J Am Coll Cardiol 1999;34:730-8. (Pubitemid 29436178)
21. Morse RW, Noe S, Caravalho J Jr, Balingit A, Taylor AJ. Rest-redistribution 201Tl single-photon emission CT imaging for determination of myocardial viability: relationship among viability, mode of therapy, and long-term prognosis. Chest 1999;115:1621-6. (Pubitemid 29275655)
22. Shapira I, Heller I, Pines A, Topilsky M, Isakov A. The impact of myocardial viability as determined by rest-redistribution 201Tl single photon emission CT imaging and the choice of therapy on prognosis in patients with left ventricular dysfunction. J Med 2000;31:205-14. (Pubitemid 32204604)
23. Sciagrà R, Pellegri M, Pupi A, et al. Prognostic implications of Tc-99m sestamibi viability imaging and subsequent therapeutic strategy in patients with chronic coronary artery disease and left ventricular dysfunction. J Am Coll Cardiol 2000;36:739-45.
24. Sicari R, Ripoli A, Picano E, et al. The prognostic value of myocardial viability recognized by low dose dipyridamole echocardiography in patients with chronic ischaemic left ventricular dysfunction. Eur Heart J 2001;22:837-44. (Pubitemid 32622411)
25. Senior R, Kaul S, Raval U, Lahiri A. Impact of revascularization and myocardial viability determined by nitrate-enhanced Tc-99m sestamibi and Tl-201 imaging on mortality and functional outcome in is- chemic cardiomyopathy. J Nucl Cardiol 2002;9:454-62. (Pubitemid 36322177)
26. Podio V, Spinnler MT, Bertuccio G, Carbonero C, Pelosi E, Bisi G. Prognosis of hibernating myocardium is independent of recovery of function: evidence from a routine based follow-up study. Nucl Med Commun 2002;23:933-42. (Pubitemid 35178293)
27. He Z-X, Yang M-F, Liu X-J, et al. Association of myocardial viability on nitrate-augmented technetium-99m hexakis-2-methoxylisobutyl isonitrile myocardial tomography and intermediate-term outcome in patients with prior myocardial infarction and left ventricular dysfunction. Am J Cardiol 2003;92:696-9. (Pubitemid 37103021)
28. Sicari R, Picano E, Cortigiani L, et al. Prognostic value of myocardial viability recognized by low-dose dobutamine echocardiography in chronic ischemic left ventricular dysfunction. Am J Cardiol 2003; 92:1263-6. (Pubitemid 37431131)
29. Petrasinovic Z, Ostojic M, Beleslin B, et al. Prognostic value of myocardial viability determined by a 201Tl SPECT study in patients with previous myocardial infarction and mild-to-moderate myocardial dysfunction. Nucl Med Commun 2003; 24:175-81.
30. Meluzín J, Cerný J, Spinarová L, et al. Prognosis of patients with chronic coronary artery disease and severe left ventricular dysfunction: the importance of myocardial viability. Eur J Heart Fail 2003;5:85-93. (Pubitemid 36205549)
31. Liao L, Cabell CH, Jollis JG, et al. Usefulness of myocardial viability or ischemia in predicting long-term survival for patients with severe left ventricular dysfunction undergoing revascularization. Am J Cardiol 2004;93:1275-9. (Pubitemid 38595683)
32. Hage FG, Venkataraman R, Aljaroudi W, et al. The impact of viability assessment using myocardial perfusion imaging on patient management and outcome. J Nucl Cardiol 2010;17:378-89.
33. Sawada SG, Dasgupta S, Nguyen J, et al. Effect of revascularization on longterm survival in patients with ischemic left ventricular dysfunction and a wide range of viability. Am J Cardiol 2010;106:187-92.
34. Bourque JM, Hasselblad V, Velazquez EJ, Borges-Neto S, O'Connor CM. Revas- cularization in patients with coronary artery disease, left ventricular dysfunction, and viability: a meta-analysis. Am Heart J 2003;146:621-7. (Pubitemid 37281705)
35. Jones RH, White H, Velazquez EJ, et al. STICH (Surgical Treatment for Ischemic Heart Failure) trial enrollment. J Am Coll Cardiol 2010;56:490-8.
36. Di Carli MF, Davidson M, Little R, et al. Value of metabolic imaging with positron emission tomography for evaluating prognosis in patients with coronary artery disease and left ventricular dysfunction. Am J Cardiol 1994;73:527-33. (Pubitemid 24142581)
37. Beanlands RS, Nichol G, Huszti E, et al. F-18-fluorodeoxyglucose positron emission tomography imaging-assisted management of patients with severe left ventricular dysfunction and suspected coronary disease: a randomized, controlled trial (PARR-2). J Am Coll Cardiol 2007;50:2002-12. (Pubitemid 350054917)
38. Kim RJ, Wu E, Rafael A, et al. The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. N Engl J Med 2000;343: 1445-53.
39. Wellnhofer E, Olariu A, Klein C, et al. Magnetic resonance low-dose dobutamine test is superior to SCAR quantification for the prediction of functional recovery. Circulation 2004;109:2172-4. (Pubitemid 38625392)
40. Schinkel AFL, Bax JJ, Poldermans D, Elhendy A, Ferrari R, Rahimtoola SH. Hibernating myocardium: diagnosis and patient outcomes. Curr Probl Cardiol 2007;32:375-410. (Pubitemid 46881171)
41. Camici PG, Prasad SK, Rimoldi OE. Stunning, hibernation, and assessment of myocardial viability. Circulation 2008; 117:103-14. (Pubitemid 350301145)
42. Seghatol FF, Shah DJ, DiLuzio S, et al. Relation between contractile reserve and improvement in left ventricular function with beta blocker therapy in patients with heart failure secondary to ischemic or id-iopathic dilated cardiomyopathy. Am J Cardiol 2004;93:854-9. (Pubitemid 38429596)
43. Bello D, Shah DJ, Farah GM, et al. Gadolinium cardiovascular magnetic resonance predicts reversible myocardial dysfunction and remodeling in heart failure patients undergoing beta-blocker therapy. Circulation 2003;108:1945-53. (Pubitemid 37296539)
44. Cleland JG, Pennell DJ, Ray SG, et al. Myocardial viability as a determinant of the ejection fraction response to carve- dilol in patients with heart failure (CHRISTMAS trial): randomised controlled trial. Lancet 2003;362:14-21. (Pubitemid 36840896)
45. Douglas PS, Taylor A, Bild D, et al. Outcomes research in cardiovascular imaging: report of a workshop sponsored by the National Heart, Lung, and Blood Institute. JACC Cardiovasc Imaging 2009;2: 897-907.